The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a loss of -36.53%.However, over the last six months, we can see a stronger performance of -48.54%. Over the last 30 days, the price of ALXO has leaped by -14.52%. And in the last five days, it has fallen by -3.64%.
In terms of market performance, Alx Oncology Holdings Inc had a fairly uneven. The highest value for the stock in the past year was $17.83 on 05/07/24, and the lowest value was recorded at $0.95 on 03/04/25.
52-week price history of ALXO Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Alx Oncology Holdings Inc’s current trading price is -94.05% away from its 52-week high, while its distance from the 52-week low is 12.00%. The stock’s price range during this time has been between $0.95 and $17.83. The trading volume for the Healthcare sector company’s shares reached about 3.4 million for the day, which was higher than the average daily volume of 1.24 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Alx Oncology Holdings Inc (ALXO) has experienced a quarterly decline of -31.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 56.59M and boasts a workforce of 80 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4468, with a change in price of -0.3800. Similarly, Alx Oncology Holdings Inc recorded 1,115,332 in trading volume during the last 100 days, posting a change of -26.39%.
ALXO’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ALXO stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.13.
ALXO Stock Stochastic Average
Today, Alx Oncology Holdings Inc’s raw stochastic average for the past 50 days stands at 11.15%, indicating a decline from the raw stochastic average of the last 20 days, which was 20.52%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 37.81% and 30.73% respectively.
